CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reinke, V.
Right arrow Articles by Lozano, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reinke, V.
Right arrow Articles by Lozano, G.
Cell Growth & Differentiation Vol. 10, 147-154, March 1999
© 1999 American Association for Cancer Research

Overproduction of MDM2 in Vivo Disrupts S Phase Independent of E2F11

Valerie Reinke, Donna M. Bortner, Lisa L. Amelse, Karen Lundgren2, Michael P. Rosenberg, Cathy A. Finlay and Guillermina Lozano3

Department of Molecular Genetics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030 [V. R., L. L. A., G. L.]; and Glaxo Wellcome Research and Development, Research Triangle Park, North Carolina 27709 [D. M. B., K. L., M. P. R., C. A. F.]

Expression of a ß-lactoglobulin (BLG)/mdm2 transgene (BLGmdm2) in the epithelial cells of the mouse mammary gland causes an uncoupling of S phase from M phase, resulting in polyploidy and tumor formation. The cell cycle defects are independent of interactions with p53. Because MDM2 also binds and activates the S phase-specific transcription factor E2F1, we hypothesized that increased E2F1 activity causes the development of the BLGmdm2 phenotype. We, therefore, generated BLGmdm2 mice that were null for E2F1. We observed no notable differences in histology or cyclin gene expression between BLGmdm2 and BLGmdm2/E2F1-/- mice, indicating that endogenous E2F1 activity was not required for the BLGmdm2 phenotype. Because, depending on the experimental system, either loss of E2F1 function or overexpression of E2F1 results in transformation, we also tested whether overexpression of E2F1 augmented the severity of the BLGmdm2 phenotype by generating mice that were bitransgenic for BLGmdm2 and BLGE2F1. We observed a unique mixture of the two single transgenic phenotypes histologically and found no significant changes in cyclin levels, indicating that overexpression of E2F1 had no effect on the BLGmdm2 transgenic phenotype. Thus, increased expression or absence of E2F1 does not affect the ability of MDM2 to disrupt the cell cycle.




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
G. Ganguli and B. Wasylyk
p53-Independent Functions of MDM2
Mol. Cancer Res., December 1, 2003; 1(14): 1027 - 1035.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K.-J. Sohn, S. A. Shah, S. Reid, M. Choi, J. Carrier, M. Comiskey, C. Terhorst, and Y.-I. Kim
Molecular Genetics of Ulcerative Colitis-associated Colon Cancer in the Interleukin 2- and {beta}2-Microglobulin-deficient Mouse
Cancer Res., September 1, 2001; 61(18): 6912 - 6917.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
T. Zhang and C. Prives
Cyclin A-CDK Phosphorylation Regulates MDM2 Protein Interactions
J. Biol. Chem., August 10, 2001; 276(32): 29702 - 29710.
[Abstract] [Full Text] [PDF]


Home page
EMBO J.Home page
G. Ganguli, J. Abecassis, and B. Wasylyk
MDM2 induces hyperplasia and premalignant lesions when expressed in the basal layer of the epidermis
EMBO J., October 2, 2000; 19(19): 5135 - 5147.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. L. Yang, Y. B. Dong, M. J. Elliott, T. J. Liu, C. Atienza Jr., A. Stilwell, and K. M. McMasters
Adenovirus-mediated E2F-1 Gene Transfer Inhibits MDM2 Expression and Efficiently Induces Apoptosis in MDM2-overexpressing Tumor Cells
Clin. Cancer Res., August 1, 1999; 5(8): 2242 - 2250.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
T. Zhang and C. Prives
Cyclin A-CDK Phosphorylation Regulates MDM2 Protein Interactions
J. Biol. Chem., August 10, 2001; 276(32): 29702 - 29710.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1999 by the American Association of Cancer Research.